Texas Heart Institute Home
Continuing Medical Education
 
CME Home
 

 
Upcoming Symposium - Future Direction of Stem Cells in CV Disease - March 2013  
 
Future Direction 
of Stem Cells in
Cardiovascular Disease 

Presented by
Texas Heart Institute

Friday, March 8, 2013
6:00 to 9:00 p.m.

The Westin Market Street
San Francisco, California
 
This educational activity is not part of ACC.13;however, the content was reviewed and approved by the ACC.13 Program Committee.
  

Upcoming symposium brochure
 


Online registration is now closed.
Please see note below.

 

Due to the popularity of this event, priority seating is available until 5:45 p.m. for pre-registered attendees who arrive by this time. Seating will be available to on-site registrants after 5:45 p.m. 

 
Overview

The study of adult stem cells and their role in treating cardiovascular disease is quickly becoming an acceptable mode of treatment. The challenge remains to identify the very best types of stem cells, refine our delivery techniques, and establish the most effective doses of stem cells.

Target Audience
Cardiologists desiring to further their knowledge of how stem cells play a role in heart failure, acute myocardial infarction, and peripheral vascular disease will find the discussions timely and relevant to their practice in providing improved patient care.

The goal of this symposium is to educate physicians on the clinical application of stem cells in cardiovascular disease.

Learning Objectives
At the conclusion of this symposium, participants should be able to–

  • Summarize recent scientific advances related to the use of stem cells in treating heart failure, acute myocardial infarction and peripheral vascular disease.
  • Describe the mechanism of action of cell therapy in the treatment of cardiovascular disease.
  • Discuss the use of stem cells in the regeneration of damaged heart tissues.

Preliminary Program 

Friday March 8, 2013  

6:00 p.m.  Buffet Open

6:15 p.m.  Welcome and Introductions         

6:20 p.m.   Stem Cells in Cardiovascular Disease:
                   Where Are We Today?

                James T. Willerson, MD

6:40 p.m.   Peripheral Vascular Disease and Stem Cell Therapy
                Emerson C. Perin, MD, PhD

7:00 p.m.   Cell Therapy of Acute ST Elevation Myocardial Infarction
                Andreas M. Zeiher, MD

7:20 p.m.   Building Autologous Biologic Solutions for Injured Heart
                Doris Taylor, PhD

7:40 p.m.   MPCs in Treating Chronic Myocardial Ischemia
                    in Patients with and without CAD

                Emerson C. Perin, MD, PhD

8:00 p.m.   Break
                

8:20 p.m.   cKit Stem Cell Therapy of Ischemic Cardiomyopathy
                Joshua Hare, MD

8:40 p.m.   The Next Frontier: Molecules and Mechanisms
                   for Making Heart Muscle
         
       Jay Schneider, MD, PhD

9:00 p.m.   Adjourn

  
Details in final brochure.

 

Program Director


Dr. James T. Willerson

 

James T. Willerson, MD
President and Medical Director
Texas Heart Institute at
St. Luke's Episcopal Hospital

Accreditation

Texas Heart Institute at St. Luke's Episcopal Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Texas Heart Institute at St. Luke's Episcopal Hospital designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

An evaluation form sent post event will provide each participant the opportunity to review the speakers, to identify educational needs, and to comment on any perceived commercial or promotional bias in the presentation.

Meeting Site

The symposium will be held at 
The Westin San Francisco Market Street
50 Third Street
San Francisco, California 94103
415-974-6400

Cancellation Policy
The Texas Heart Institute reserves the right to cancel the symposium if enrollment is deemed insufficient.
  

Registration 

Online registration is now closed. Please see note below.

Due to the popularity of this event, priority seating is available until 5:45 p.m. for pre-registered attendees who arrive by this time. Seating will be available to on-site registrants after 5:45 p.m.

 
Find Us on Facebook!

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
� Copyright Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.


U.S. NEWS America's Best Hospitals 2012-13